DNA Brands, Inc.
DNAX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $528 | $475 | $2,082 | $30,168 |
| - Cash | $0 | $0 | $2 | $67 |
| + Debt | $3,060 | $2,812 | $2,208 | $2,011 |
| Enterprise Value | $3,587 | $3,286 | $4,288 | $32,113 |
| Revenue | $0 | $0 | $0 | $459 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $456 |
| % Margin | – | – | – | 99.2% |
| EBITDA | -$250 | $16 | -$338 | -$300 |
| % Margin | – | – | – | -65.3% |
| Net Income | -$523 | -$703 | -$375 | -$304 |
| % Margin | – | – | – | -66.2% |
| EPS Diluted | -0 | -0.001 | -0.001 | -0.001 |
| % Growth | 80% | -42.9% | -16.7% | – |
| Operating Cash Flow | -$12 | – | -$421 | -$434 |
| Capital Expenditures | -$0 | – | $0 | -$0 |
| Free Cash Flow | -$12 | – | -$421 | -$434 |